Comprehensive Cardiac Rehabilitation Feasibility After Stroke
NCT ID: NCT03944668
Last Updated: 2023-05-16
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
17 participants
INTERVENTIONAL
2019-04-29
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adapted Cardiac Rehabilitation After Stroke
NCT01067495
Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)
NCT05651945
Cardiac Rehabilitation for TIA Patients
NCT00536562
Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE)
NCT04938661
Cardiac Rehabilitation and Coronary Artery Disease
NCT06579807
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Exercise intervention
Exercise
36 sessions of comprehensive cardiac rehabilitation over 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
36 sessions of comprehensive cardiac rehabilitation over 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient has suffered an ischemic stroke
* Patient should be ambulatory (non-disabling stroke) to be able to participate in the CCR exercise program
* Patient is able to start cardiac rehabilitation within 2 weeks of stroke
Exclusion Criteria
* Life expectancy \< 1-year
* Presence of brain hemorrhage: intracerebral hemorrhage, subarachnoid hemorrhage, subdural hematoma, or epidural hematoma
* Concurrent diagnosis of seizure disorder
* Patient with moderate or severe neurologic deficits, limiting their ability to participate in the CCR exercise program
* Cardiopulmonary conditions preventing the patient from participation, such as severe heart failure, severe aortic stenosis, and exercise-induced asthma
* Patient with cognitive dysfunction impairing their ability to follow directions
* Anticipated procedures such as carotid stenting, carotid endarterectomy, and intracranial aneurysm coiling
* Patient unable to commit to the frequent visits of the CCR program
* Participation in other interventional research (observational research is allowed)
* Unable to have brain MRI
* Non-English speaker
* Pregnant women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HealthPartners Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Haitham M Hussein, MD
Role: PRINCIPAL_INVESTIGATOR
Regions Hospital Stroke Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Regions Hospital
Saint Paul, Minnesota, United States
Regions Hospital Outpatient Cardiopulmonary Rehabilitation Clinic
Saint Paul, Minnesota, United States
HealthPartners Neuroscience Center
Saint Paul, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-361
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.